Effektivität von Dupilumab (Dupixent®) in der Therapie der chronischen Rhinosinusitis mit nasalen Polypen: Erste Ergebnisse aus Hamburg | Zendy

AI Assistant Blog Pricing

Open Access

Effektivität von Dupilumab (Dupixent®) in der Therapie der chronischen Rhinosinusitis mit nasalen Polypen: Erste Ergebnisse aus Hamburg

Author(s) -

AS Hoffmann,

Jan-Luca Eden,

Florian Jansen,

Philippe Christophe Breda,

Christian Betz

Publication year - 2021

Publication title -

laryngo-rhino-otologie

Language(s) - German

Resource type - Conference proceedings

eISSN - 1438-8685

pISSN - 0935-8943

DOI - 10.1055/s-0041-1728610

Subject(s) - dupilumab , chronic rhinosinusitis , medicine , gynecology , dermatology , atopic dermatitis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.